Stramsen Biotech Submits Pre-IND to FDA for SBX 1977 Trial
August 28, 2025
A Revolutionary Plant-based Drug for Wound Healing; Seeks Guidance on Advancing Directly to Phase 2 Clinical Trials Stramsen Biotech Inc. has successfully submitted a Pre-Investigational New